Arta Monjazeb, MD
Michael Kent, DVM
UC Davis Comprehensive Cancer Center, Sacramento, California
With few exceptions, metastatic sarcomas and melanomas are incurable. At UC Davis Comprehensive Cancer Center, we have embarked on a novel study to improve these odds by combining radiotherapy and immune therapy. The research has shown good results so far in laboratory mice and promising results in a preliminary clinical trial of companion dogs with spontaneous tumors.
Patients with metastatic melanoma or with metastatic sarcoma are typically treated with chemotherapy, but with very limited success. Our approach harnesses the immune system to recognize the cancer and eliminate it as it would an infection.
... to read the full story